TAK-593 - CAS# 1005780-62-0 ifluorothymidine InChi: InChI=1S/C20H11N5OS/c21-11-13-16-10-12(22-20(26)17-6-3-9-27-17)7-8-25(16)19-18(13)23-14-4-1-2-5-15(14)24-19/h1-10H

InChi: InChI=1S/C20H11N5OS/c21-11-13-16-10-12(22-20(26)17-6-3-9-27-17)7-8-25(16)19-18(13)23-14-4-1-2-5-15(14)24-19/h1-10H

Pharmacological characterization of a novel cannabinoid ligand

Chemical Name: N-(2-{[(2E)-3

Benznidazole is a nitroimidazole antiparasitic with good activity against acute infection with Trypanosoma cruzi

InChiKey: GOADIQFWSVMMRJ-UPGAGZFNSA-N

TAK-593 - CAS# 1005780-62-0 ifluorothymidine InChi: InChI=1S/C20H11N5OS/c21-11-13-16-10-12(22-20(26)17-6-3-9-27-17)7-8-25(16)19-18(13)23-14-4-1-2-5-15(14)24-19/h1-10HTAK 593 is a n oral formulation containing a small molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK 593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation. Product information CAS Number: 1005780 62 0 Molecular Weight: 445.